Taiwan's National Health Insurance (NHI) system has approved its first-ever patient to receive a one-time NT$49 million (US$1.53 million) drug for spinal muscular atrophy (SMA), which was added to a list of covered treatments earlier this month, an official said Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
TSMC evacuates employees following earthquakes
01/21/2025 03:56 AM - Politics
President Lai congratulates Trump on inauguration
01/21/2025 02:25 AM - Society
3 reportedly trapped in quake-damaged building in Tainan
01/21/2025 02:10 AM - Society
Magnitude 6.4 earthquake strikes southern Taiwan
01/21/2025 12:47 AM - Politics
Taiwanese group gets indoor invite to Trump's swearing-in livestream
01/20/2025 10:10 PM